Sources | Names Used |
---|---|
CTRPv2 | triazolothiadiazine |
PharmacoGx | triazolothiadiazine |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LONRF1 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
mRNA | ALDH3B1 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-07 |
mRNA | TYMS | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-07 |
mRNA | PCM1 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-07 |
mRNA | METAP1 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-07 |
mRNA | TTLL12 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-07 |
mRNA | ZNF397 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-07 |
mRNA | PFAS | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-07 |
mRNA | SUMF1 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-07 |
mRNA | REEP5 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-07 |